Eli Lilly (LLY) PT Raised to $106 at Societe Generale
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,199.43 -2.48%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 39
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 39
Join SI Premium – FREE
Societe Generale analyst Florent Cespedes raised the price target on Eli Lilly (NYSE: LLY) to $106.00 while maintaining a Hold rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
- Arca Continental SAB de CV (AC*:MM) (EMBVF) PT Raised to Peso250 at Citi
- Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
